FindTrial
Sign In

Omega 3 fatty acids in surgery and inflammation

Peri operative Omega 3 fatty acids for surgery induced SIRS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100112
Enrollment
200
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified

Interventions

Intervention1: Omega 3 fatty acids: Study group will be administered O3FA in the dose of 0.2mg/kg/day on day prior to surgery The same dose will be given for 4 days in the postop period also starting

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Major abdominal cancer surgeries 2. Major head and neck cancer surgeries

Exclusion criteria

Exclusion criteria: Patients with coagulopathies Patients who are on aspirin which is not stopped at least 3 days before surgery Patients who have preop infection or sepsis Patients allergic to fish and seafood Patients with severe hepatic or renal dysfunction Patients below 18 yrs and older than 80 years Patient s refusal to be infused with fish oil

Design outcomes

Primary

MeasureTime frame
Comparison of Inflammatory markersTimepoint: Comparison of Inflammatory markers at Day 1 and Day 3—

Secondary

MeasureTime frame
Return of bowel movements, any SSI, LOSH, postop deliriumTimepoint: Upto 10 days after surgery—

Countries

India

Contacts

Public ContactNK Vinod

Sri Shankara Cancer Hospital and Research Centre

nkvinod@hotmail.com09980761214

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026